DNTH
Dianthus Therapeutics, Inc. · Healthcare
Fairmount Funds Management LLC bought $336K of Dianthus Therapeutics, Inc.
Director and 10% owner
Bought$336,252
$13.63Price
24,670Shares
+1%Stake
What DNTH did for a copier
- $1,000 copied at Wed, Oct 4 open, $12.90
- $899
- S&P 500, same days
- +6.5%
Measured over 30 trading days, to the Nov 15 close.
Fairmount Funds Management LLC's record
17 other buys with 3 months of prices since 2021: on average −9.3% against the S&P 500, and 6 of 17 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Sep 29. Filed Tue, Oct 3, 4:00 PM ET, after the close. Returns use the Oct 4 open and the Nov 15 close. Not investment advice.